Production
Pharma
Dispensaries
Investors
Sales and Operations
Consumer
Events and Networking
Politics and Law
Production
Pharma
Dispensaries
Investors
Sales and Operations
Consumer
Events and Networking
Politics and Law
Pharma
22nd Century Group acquires GVB Biopharma, a leading hemp/cannabis company
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the acquisition of privately held GVB Biopharma....
FSD Pharma Announces Closing of Business Combination and Conditional Approval from the CSE
FSD Pharma Inc. (formerly, Century Financial Capital Group Inc., the “Corporation”) announced that it has completed its previously announced business combination with FV Pharma Inc. (“FV Pharma”). On March 9, 2018, the Corporation and FV Pharma entered into an arm’s...
Experts warn that ‘patient influencers’ are being paid by big pharma companies to hawk drugs to US consumers without telling them
As trust in the pharmaceutical companies wanes in the U.S., the firms are turning towards 'patient influencers' to use trusted figures in online communities to help hawk drugs to patients, experts warn. A team at the University of Colorado, Boulder, warns in a report...
Medical cannabis to be sold at pharmacies in Greece
Greece expects huge investments in the production of medical cannabis which the government hopes would add up to 1.5 billion euros ($1.67 billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said. Speaking exclusively to Greek...
State of Mississippi Selects Tyler Technologies Licensing Solution for New Medical Marijuana Program
Tyler Technologies, Inc. (NYSE: TYL) announced today it has signed a five-year agreement with the state of Mississippi for Tyler’s NIC Licensing Solution (NLS), the government licensing platform designed specifically for the cannabis industry. The comprehensive...
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia, and Alzheimer's in the EU and UK MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat...
House Passes Bipartisan Marijuana Research Bill To Let Scientists Study Dispensary Products, Days After Legalization Vote
The U.S. House of Representatives on Monday approved a bipartisan marijuana research bill that’s meant to streamline studies into cannabis, in part by allowing scientists to access products from state-legal dispensaries. This comes days after the chamber separately...
Indica News
(833) 769-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Quicklinks
Follow Us
Indica News
(833) 450-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Follow Us
Quicklinks
Indica News
(833) 450-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM